Shots:
- J&J MedTech has launched the Cereglide 92 Catheter System with the Innerglide 9 delivery aid in the US to ease insertion & guidance of interventional devices in the neurovascular system
- Cereglide 92 features a .092” inner diameter with Innerglide 9 delivery aid, Brite-line tech for complete catheter visibility, & TruCourse for flexibility to provide large distal access, reduced flow in M1, & distal support for multiple neurovascular tools for treating acute ischemic stroke, aneurysms, & hemorrhagic complications
- Additionally, Cereglide 92 allows physicians to restore blood flow in the brain during thrombectomy by directly removing blood clots or by deploying a stent retriever
Ref: Johnson & Johnson | Image: Johnson & Johnson
Related News:- Johnson & Johnson Receives the CHMP Positive Opinion on Label Extension to SC Rybrevant for the Treatment of Advanced EGFR-Mutated NSCLC
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
